Lorem ipsum dolor sit
amet consectetur adipisicing elit.
Porro obcaecati cupiditate sequi voluptatem eos laborum modi ipsa, repellat voluptate vero, quo autem fugiat in quis? Commodi aliquam doloribus corrupti inventore.
What's coming down the drug pipeline in 2025? New therapies and exciting opportunities to transform patient care—but only for health systems ready to seize them.
“With 50 novel drug therapy approvals last year, 2024 was another strong year for specialty drug development, and the 2025 pipeline promises more of the same,” predicts market access expert Amber Skrtic, PharmD, CSP, AAHIVP in a new article featured in the Becker’s Hospital Review newsletter.
Dr. Skrtic identifies 4 key updates that pose significant opportunities for health systems this year. 
Find out what’s in store and how your organization can prepare by reading the full article.
Fill out the form below to see the market trends.
2025 Specialty Drug Pipeline: 4 Opportunities for Health Systems
By Amber Skrtic, PharmD, CSP, AAHIVP
How Does Your Hospital Pharmacy Benefit?
-
-
IN-DEPTH ASSESSMENTS We review clinical and financial performance, regulatory requirements, compliance status, standards of practice, accreditation standards, policies and procedures, and more
-
-
GUIDANCE BY PHARMACY PRACTICE SPECIALISTS We advise your pharmacy while addressing performance barriers and introducing a culture of continuous improvement
-
-
CORRECTIVE ACTION PLANS We benchmark performance and identify opportunities
-
-
SPECIAL COMPLIANCE PROGRAM We deliver keen focus on 340B programs, USP 797/800, controlled substance risk, accreditation readiness, and more
-
-
LEVERAGE OUR YEARS OF EXPERIENCE CPS has delivered over 250 customized sterile compounding consultative assessments for diverse compounding operations
-
-
RECEIVE A COMPLETE SITE ASSESSMENT using our proprietary audit tool
-
-
RECEIVE A DETAILED EVALUATION OF STAFF AND SYSTEMS including personnel training and evaluation, an operational review, and more
-
-
FOLLOWING ASSESSMENT, CPS will deliver a written compliance report and a corrective action plan detailing findings and recommendations to bring your compounding pharmacy into regulatory compliance.
-
-
CPS WORKS WITH YOUR THIRD-PARTY ADMINISTRATORS to capture the claims which now meet the standards for inclusion in your 340B program
-
-
YOUR ORGANIZATIONAL REVENUE INCREMENTALLY IMPROVES FROM THIS PROCESS
Case Study: How Drew Memorial Slashed Total Drug Spend to <$20 PPD